SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001104659-06-071765
Filing Date
2006-11-06
Accepted
2006-11-06 17:30:43
Documents
5
Period of Report
2006-09-30

Document Format Files

Seq Description Document Type Size
1 QUARTERLY REPORT PURSUANT TO SECTIONS 13 OR 15(D) a06-21394_110q.htm 10-Q 767056
2 EX-10 a06-21394_1ex10d37.htm EX-10.37 28494
3 EX-31 a06-21394_1ex31d1.htm EX-31.1 9409
4 EX-31 a06-21394_1ex31d2.htm EX-31.2 9544
5 EX-32 a06-21394_1ex32.htm EX-32 8902
  Complete submission text file 0001104659-06-071765.txt   824890
Mailing Address 901 GATEWAY BLVD S. SAN FRANCISCO CA 94080
Business Address 901 GATEWAY BLVD SOUTH SAN FRANCISCO CA 94080 6508086000
THERAVANCE INC (Filer) CIK: 0001080014 (see all company filings)

IRS No.: 943265960 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-30319 | Film No.: 061191419
SIC: 2834 Pharmaceutical Preparations